Aerie Pharma (AERI) Tops Q2 EPS by 24c

Aerie Pharma (NASDAQ: AERI) reported Q2 EPS of ($0.32), $0.24 better than the analyst estimate of ($0.56). Revenue for the quarter came in at $33 million versus the consensus estimate of $32.49 million.

For earnings history and earnings-related data on Aerie Pharma (AERI) click here.

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Bio-key International, Inc. (BKYI) Tops Q2 EPS by 24c
• Cheetah Net Supply Chain Service Inc. (CTNT) Reports Q2 EPS of $0.04